Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Godkin

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|March 6, 2021
Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cellsAmanda Thomson, Diana F Costa Bento, Martin J Scurr, et al.
British Journal of Cancer|August 19, 2022
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansionSarah N Lauder, Kathryn Smart, Valentina M T Bart, et al.
World Journal of Hepatology|February 6, 2023
Rising incidence, progression and changing patterns of liver disease in Wales 1999-2019Thomas Peter Ignatius Pembroke, Gareth John, Berry Puyk, et al.
Journal for Immunotherapy of Cancer|February 2, 2026
Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse eventsSarah Nicol Lauder, Ana Pires, Michelle Somerville, et al.
Journal of the National Cancer Institute|February 12, 2015
Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancerMartin J Scurr, Clare M Brown, Diana F Costa Bento, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2018
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine designMatthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2020
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletionEllyn Hughes, Sarah N Lauder, Kathryn Smart, et al.
Gut|December 31, 2011
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancerGareth Betts, Emma Jones, Syed Junaid, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patientsJessica Oliver, Hannah Reed, Lorenzo Capitani, et al.
Cancer Research Communications|January 27, 2023
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T CellsStefan Milutinovic, Jun Abe, Emma Jones, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|March 6, 2021
Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cellsAmanda Thomson, Diana F Costa Bento, Martin J Scurr, et al.
British Journal of Cancer|August 19, 2022
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansionSarah N Lauder, Kathryn Smart, Valentina M T Bart, et al.
World Journal of Hepatology|February 6, 2023
Rising incidence, progression and changing patterns of liver disease in Wales 1999-2019Thomas Peter Ignatius Pembroke, Gareth John, Berry Puyk, et al.
Journal for Immunotherapy of Cancer|February 2, 2026
Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse eventsSarah Nicol Lauder, Ana Pires, Michelle Somerville, et al.
Journal of the National Cancer Institute|February 12, 2015
Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancerMartin J Scurr, Clare M Brown, Diana F Costa Bento, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2018
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine designMatthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, et al.
Cancer Immunology, Immunotherapy : CII|May 25, 2020
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletionEllyn Hughes, Sarah N Lauder, Kathryn Smart, et al.
Gut|December 31, 2011
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancerGareth Betts, Emma Jones, Syed Junaid, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patientsJessica Oliver, Hannah Reed, Lorenzo Capitani, et al.
Cancer Research Communications|January 27, 2023
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T CellsStefan Milutinovic, Jun Abe, Emma Jones, et al.
Pageof 7